Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients

Detalles Bibliográficos
Autores principales: Zampieri, Fernando G., Ginde, Adit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887006/
https://www.ncbi.nlm.nih.gov/pubmed/34910598
http://dx.doi.org/10.1164/rccm.202111-2593ED

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887006/
https://www.ncbi.nlm.nih.gov/pubmed/34910598
http://dx.doi.org/10.1164/rccm.202111-2593ED

Ejemplares similares